medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Número S1

<< Anterior Siguiente >>

Acta Ortop Mex 2013; 27 (S1)


Tratamiento de las heridas

Idioma: Español
Referencias bibliográficas: 52
Paginas: 109-121
Archivo PDF: 230.17 Kb.


FRAGMENTO

Pregunta 1A: ¿Cuál es el apósito ideal para cubrir una herida después de una artroplastía total (AT)?

Consenso: Recomendamos el uso de un apósito oclusivo con alginatos e hidrofibras cuando éstos se encuentren disponibles.
Voto de los delegados: de acuerdo, 63%; en desacuerdo, 25%; abstenciones, 12%. (Consenso débil.)


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Clarke JV, Deakin AH, Dillon JM, Emmerson S, Kinninmonth AW: A prospective clinical audit of a new dressing design for lower limb arthroplasty wounds. J Wound Care. 2009; 18(1): 5-8, 10-11.

  2. Burke NG, Green C, McHugh G, McGolderick N, Kilcoyne C, Kenny P: A prospective randomized study comparing the jubilee dressing method to a standard adhesive dressing for total hip and knee replacements. J Tissue Viability. 2012; 21(3): 84-87.

  3. Hopper GP, Deakin AH, Crane EO, Clarke JV: Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit. J Wound Care. 2012; 21(4): 200-203.

  4. Abuzakuk TM, Coward P, Shenava Y, Kumar VS, Skinner JA: The management of wounds following primary lower limb arthroplasty: a prospective, randomized study comparing hydrofibre and central pad dressings. Int Wound J. 2006; 3(2): 133-137.

  5. Ravenscroft MJ, Harker J, Buch KA: A prospective, randomised, controlled trial comparing wound dressings used in hip and knee surgery: Aquacel and Tegaderm versus Cutiplast. Ann R Coll Surg Engl. 2006; 88(1): 18-22.

  6. Ubbink DT, Vermeulen H, Goossens A, Kelner RB, Schreuder SM, Lubbers MJ: Occlusive versus gauze dressings for local wound care in surgical patients: a randomized clinical trial. Arch Surg. 2008; 143(10): 950-955.

  7. Foster L, Moore P, Clark S: A comparison of hydrofibre and alginate dressings on open acute surgical wounds. J Wound Care. 2000; 9(9): 442-445.

  8. Ravnskog FA, Espehaug B, Indrekvam K: Randomized clinical trial comparing Hydrofiber and alginate dressings post-hip replacement. J Wound Care. 2011; 20(3): 136-142.

  9. Trial C, Darbas H, Lavigne JP, et al: Assessment of the antimicrobial effectiveness of a new silver alginate wound dressing: a RCT. J Wound Care. 2010; 19(1): 20-26.

  10. Jude EB, Apelqvist J, Spraul M, Martini J: Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med. 2007; 24(3): 280-288.

  11. Jurczak F, Dugre T, Johnstone A, Offori T, Vujovic Z, Hollander D: Randomized clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J. 2007; 4(1): 66-76.

  12. Beele H, Meuleneire F, Nahuys M, Percival SL: A prospective randomized open label study to evaluate the potential of a new silver alginate/carboxymethylcellulose antimicrobial wound dressing to promote wound healing. Int Wound J. 2010; 7(4): 262-270.

  13. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT: Topical silver for treating infected wounds. Cochrane Database Syst Rev. 2007; (1): CD005486.

  14. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H: Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010; (3): CD006478.

  15. Saba SC, Tsai R, Glat P: Clinical evaluation comparing the efficacy of Aquacel ag hydrofiber dressing versus petrolatum gauze with antibiotic ointment in partial-thickness burns in a pediatric burn center. J Burn Care Res. 2009; 30(3): 380-385.

  16. Springer BD, Odum S, Griffin WL, Beaver WB, Mason JB: The role of surgical dressing in total joint arthroplasty: level 1 randomized clinical trial. Clin Orthop Relat Res. in Press.

  17. Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J: Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008; 466(6): 1368-1371.

  18. Hansen E, Durinka JB, Costanzo JA, Austin MS, Deirmengian GK: Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty. Clin Orthop Relat Res. 2013. Epub before print.

  19. Butt U, Ahmad R, Aspros D, Bannister GC: Factors affecting wound ooze in total knee replacement. Ann R Coll Surg Engl. 2011; 93(1): 54-56.

  20. Lonner JH, Lotke PA: Aseptic complications after total knee arthroplasty. J Am Acad Orthop Surg. 1999; 7(5): 311-324.

  21. Saleh K, Olson M, Resig S, et al: Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002; 20(3): 506-515.

  22. Vince K, Chivas D, Droll KP. Wound complications after total knee arthroplasty. J Arthroplasty. 2007; 22(4 Suppl 1): 39-44.

  23. Dennis DA: Wound complications in total knee arthroplasty. Instr Course Lect. 1997; 46: 165-169.

  24. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE: Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007; 89(1): 33-38.

  25. Surin VV, Sundholm K, Backman L: Infection after total hip replacement. With special reference to a discharge from the wound. J Bone Joint Surg Br. 1983; 65(4): 412-418.

  26. Weiss AP, Krackow KA: Persistent wound drainage after primary total knee arthroplasty. J Arthroplasty. 1993; 8(3): 285-289.

  27. Pachowsky M, Gusinde J, Klein A, et al: Negative pressure wound therapy to prevent seromas and treat surgical incisions after total hip arthroplasty. Int Orthop. 2012; 36(4): 719-722.

  28. Masden D, Goldstein J, Endara M, Xu K, Steinberg J, Attinger C: Negative pressure wound therapy for at-risk surgical closures in patients with multiple comorbidities: a prospective randomized controlled study. Ann Surg. 2012; 255(6): 1043-1047.

  29. Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev. 2012; 4: CD009261.

  30. Kelm J, Schmitt E, Anagnostakos K: Vacuum-assisted closure in the treatment of early hip joint infections. Int J Med Sci. 2009; 6(5): 241-246.

  31. Wilson MG, Kelley K, Thornhill TS: Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990; 72(6): 878-883.

  32. Gardner J, Gioe TJ, Tatman P: Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. Clin Orthop Relat Res. 2011; 469(4): 970-976.

  33. Galat DD, McGovern SC, Larson DR, Harrington JR, Hanssen AD, Clarke HD: Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am. 2009; 91(1): 48-54.

  34. Gherini S, Vaughn BK, Lombardi AV Jr, Mallory TH: Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop Relat Res. 1993; (293): 188-195.

  35. Lavernia CJ, Sierra RJ, Baerga L: Nutritional parameters and short term outcome in arthroplasty. J Am Coll Nutr. 1999; 18(3): 274-278.

  36. Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT: Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010; 92(7): 929-934.

  37. Jamsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T: Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7,181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am. 2012; 94(14): e101.

  38. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999; 22(9): 1408-1414.

  39. Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL: Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012; 27(5): 726-729 e721.

  40. Adams AL, Paxton EW, Wang JQ, et al: Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013; 95(6): 481-487.

  41. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH: Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007; 22(6 Suppl 2): 24-28.

  42. Mortazavi SM, Hansen P, Zmistowski B, Kane PW, Restrepo C, Parvizi J: Hematoma following primary total hip arthroplasty: a grave complication. J Arthroplasty. 2013; 28(3): 498-503.

  43. Kotze A, Carter LA, Scally AJ: Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012; 108(6): 943-952.

  44. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J: Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012; 470(10): 2695-2701.

  45. Atkins BL, Athanasou N, Deeks JJ, et al: Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998; 36(10): 2932-2939.

  46. Burnett RS, Aggarwal A, Givens SA, McClure JT, Morgan PM, Barrack RL: Prophylactic antibiotics do not affect cultures in the treatment of an infected TKA: a prospective trial. Clin Orthop Relat Res. 2010; 468(1): 127-134.

  47. Tetreault MW, Wetters NG, Aggarwal V, Mont M, Parvizi J, Della Valle CJ: The chitranjan ranawat award: should prophylactic antibiotics be with held before revision surgery to obtain appropriate cultures? Clin Orthop Relat Res. 2013. Epub before print.

  48. Khan RJ, Fick D, Yao F, et al: A comparison of three methods of wound closure following arthroplasty: a prospective, randomized, controlled trial. J Bone Joint Surg Br. 2006; 88(2): 238-242.

  49. Eggers MD, Fang L, Lionberger DR: A comparison of wound closure techniques for total knee arthroplasty. J Arthroplasty. 2011; 26(8): 1251-1258 e1251-1254.

  50. Livesey C, Wylde V, Descamps S, et al: Skin closure after total hip replacement: a randomized controlled trial of skin adhesive versus surgical staples. J Bone Joint Surg Br. 2009; 91(6): 725-729.

  51. Smith TO, Sexton D, Mann C, Donell S: Sutures versus staples for skin closure in orthopaedic surgery: meta-analysis. BMJ. 2010; 340: c1199.

  52. Coulthard P, Worthington H, Esposito M, Elst M, Waes OJ: Tissue adhesives for closure of surgical incisions. Cochrane Database Syst Rev. 2004; (2): CD004287.




2020     |     www.medigraphic.com